BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 38673867)

  • 1. Novel regulatory mechanisms of N-glycan sialylation: Implication of integrin and focal adhesion kinase in the regulation.
    Isaji T; Gu J
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130617. PubMed ID: 38614280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialyltransferase inhibition and recent advances.
    Wang L; Liu Y; Wu L; Sun XL
    Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the role of sialylation in cancer progression and metastasis.
    Dobie C; Skropeta D
    Br J Cancer; 2021 Jan; 124(1):76-90. PubMed ID: 33144696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis.
    Tsai HE; Chen CL; Chang TT; Fu CW; Chen WC; Perez SJLP; Hsiao PW; Tai MH; Li WS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling.
    Chiang CH; Wang CH; Chang HC; More SV; Li WS; Hung WC
    J Cell Physiol; 2010 May; 223(2):492-9. PubMed ID: 20112294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study.
    Perez SJLP; Chen CL; Chang TT; Li WS
    Bioorg Med Chem Lett; 2024 Jun; 105():129760. PubMed ID: 38641151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
    Chen JY; Tang YA; Huang SM; Juan HF; Wu LW; Sun YC; Wang SC; Wu KW; Balraj G; Chang TT; Li WS; Cheng HC; Wang YC
    Cancer Res; 2011 Jan; 71(2):473-83. PubMed ID: 21224350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
    Fu CW; Tsai HE; Chen WS; Chang TT; Chen CL; Hsiao PW; Li WS
    J Med Chem; 2021 Jan; 64(1):527-542. PubMed ID: 33371679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
    Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
    Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components.
    Guan G; Cannon RD; Coates DE; Mei L
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ST6GAL1 regulates monocyte-macrophage development and survival.
    Rusiniak ME; Punch PR; Hait NC; Maiti A; Burns RT; Chapla D; Moremen KW; Zhao P; Wells L; Hoffmeister K; Lau JTY
    Glycobiology; 2022 Jul; 32(8):701-711. PubMed ID: 35661210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Integrins for Cancer Therapy - Disappointments and Opportunities.
    Bergonzini C; Kroese K; Zweemer AJM; Danen EHJ
    Front Cell Dev Biol; 2022; 10():863850. PubMed ID: 35356286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAK in Cancer: From Mechanisms to Therapeutic Strategies.
    Chuang HH; Zhen YY; Tsai YC; Chuang CH; Hsiao M; Huang MS; Yang CJ
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives.
    Perez SJLP; Fu CW; Li WS
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
    Pietrobono S; Stecca B
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33921986
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.